tradingkey.logo

Rockwell Medical Inc

RMTI
0.849USD
-0.001-0.09%
收盤 12/19, 16:00美東報價延遲15分鐘
33.46M總市值
虧損本益比TTM

Rockwell Medical Inc

0.849
-0.001-0.09%

關於 Rockwell Medical Inc 公司

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Rockwell Medical Inc簡介

公司代碼RMTI
公司名稱Rockwell Medical Inc
上市日期Jan 27, 1998
CEOStrobeck (Mark)
員工數量244
證券類型Ordinary Share
年結日Jan 27
公司地址30142 Wixom Road
城市WIXOM
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編48393
電話18004493353
網址https://www.rockwellmed.com/
公司代碼RMTI
上市日期Jan 27, 1998
CEOStrobeck (Mark)

Rockwell Medical Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
105.95K
-0.83%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%

收入明細

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
地區USD
名稱
營收
佔比
United States
14.19M
0.00%
Rest of World
1.88M
0.00%
業務
地區
業務USD
名稱
營收
佔比
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%

股東統計

更新時間: 11月18日 週二
更新時間: 11月18日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.44%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
其他
84.57%
持股股東
持股股東
佔比
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.44%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
其他
84.57%
股東類型
持股股東
佔比
Corporation
9.03%
Investment Advisor
4.95%
Individual Investor
4.20%
Hedge Fund
2.01%
Investment Advisor/Hedge Fund
1.47%
Research Firm
0.09%
Venture Capital
0.04%
其他
78.21%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
98
6.21M
18.04%
-1.88M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
2023Q3
122
6.04M
24.13%
+2.56M
2023Q2
133
3.92M
24.44%
+947.21K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Irrevocable Larson Family Investment Trust
3.56M
10.33%
+87.50K
+2.52%
Apr 11, 2025
The Vanguard Group, Inc.
1.21M
3.5%
--
--
Jun 30, 2025
Renaissance Technologies LLC
541.75K
1.57%
+88.75K
+19.59%
Jun 30, 2025
Geode Capital Management, L.L.C.
320.67K
0.93%
-3.87K
-1.19%
Jun 30, 2025
Strobeck (Mark)
290.62K
0.84%
-6.93K
-2.33%
Jul 01, 2025
BlackRock Institutional Trust Company, N.A.
217.66K
0.63%
+1.98K
+0.92%
Jun 30, 2025
Ravich (Mark H)
151.10K
0.44%
+50.00K
+49.45%
May 20, 2025
Radie (Robert Samuel)
143.52K
0.42%
+50.00K
+53.46%
May 20, 2025
Timmins (Megan Carden)
142.68K
0.41%
+97.50K
+215.79%
May 20, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
佔比0.01%
Dimensional US Core Equity 1 ETF
佔比0%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
公告日期
類型
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1

常見問題

Rockwell Medical Inc的前五大股東是誰?

Rockwell Medical Inc的前五大股東如下:
Irrevocable Larson Family Investment Trust
持有股份:3.56M
佔總股份比例:10.33%。
The Vanguard Group, Inc.
持有股份:1.21M
佔總股份比例:3.50%。
Renaissance Technologies LLC
持有股份:541.75K
佔總股份比例:1.57%。
Geode Capital Management, L.L.C.
持有股份:320.67K
佔總股份比例:0.93%。
Strobeck (Mark)
持有股份:290.62K
佔總股份比例:0.84%。

Rockwell Medical Inc的前三大股東類型是什麼?

Rockwell Medical Inc 的前三大股東類型分別是:
Irrevocable Larson Family Investment Trust
The Vanguard Group, Inc.
Renaissance Technologies LLC

有多少機構持有Rockwell Medical Inc(RMTI)的股份?

截至2025Q3,共有98家機構持有Rockwell Medical Inc的股份,合計持有的股份價值約為6.21M,占公司總股份的18.04% 。與2025Q2相比,機構持股有所增加,增幅為-17.52%。

哪個業務部門對Rockwell Medical Inc的收入貢獻最大?

在FY2025Q2,Concentrate Products業務部門對Rockwell Medical Inc的收入貢獻最大,創收16.07M,占總收入的--% 。
KeyAI